Julie Rathbun | Communications |
Jonathan Drachman | CEO, President & Interim Chairman |
Kamran Alam | Interim CFO, VP, Finance & Corporate Secretary |
Tyler Van Buren | Piper Sandler & Co. |
Charles Zhu | Guggenheim Securities |
Arlinda Lee | Canaccord Genuity |
Good afternoon, and thank you for joining us today for the Neoleukin Therapeutics Conference Call. [Operator Instructions].
I will turn the call over to Julie Rathbun, Communications for Neoleukin Therapeutics. Julie, please go ahead.
Thank you.